Tecan

Morrisville,  NC 
United States
http://www.tecan.com
  • Booth: 626

Tecan is a leading global provider of automated laboratory instruments and solutions. Our systems and components help people working in clinical diagnostics, basic and translational research and drug discovery bring their science to life.

In particular, we develop, produce, market and support automated workflow solutions that empower laboratories to achieve more. Our Cavro branded instrument components are chosen by leading instrumentation suppliers across multiple disciplines.

Brands: Tecan, NuGEN, Cavro, SPEware, IBL


 Press Releases

  • Männedorf, Switzerland, August 16 2018 - The Tecan Group (SIX Swiss Exchange: TECN) announced today the acquisition of US-based NuGEN Technologies, Inc. to further expand Tecan's dedicated solutions offering into the new market segment of next-generation sequencing (NGS) reagents and thus further increasing Tecan's overall recurring revenues. NuGEN is a leading provider for innovative NGS kits and genomic sample preparation solutions for the fastest growing field within the genomics area, serving customers in life science research and applied markets. As part of Tecan's Life Sciences Business, NuGEN will benefit from Tecan's global presence, customer base and strong position serving the market with automation platforms optimized for NGS sample preparation.

    The purchase consideration of USD 54.5 million (CHF 54.1 million) will be fully paid in cash and represents a valuation of less than four times expected fiscal year 2018 sales of NuGEN. Tecan anticipates to triple NuGEN's sales in the next five years by leveraging its global presence and by expanding sales capabilities in key regions. Together with an accelerated execution of its broad genomics strategy enabled by this transaction, including NuGEN and new dedicated workstations which are already under development, Tecan expects to generate total annual sales of more than CHF 75 million through this initiative by 2023. While currently modestly loss making, Tecan expects the transaction to become accretive to earnings per share (EPS) before transaction-related amortization for 2022. The closing of the transaction is anticipated within the coming weeks.
    An expected impact of the acquisition on Tecan's 2018 financial results was published today in a separate press release announcing financial results for the first half of 2018.

    Tecan CEO Dr. David Martyr commented: "NuGEN's innovative NGS kits and genomic sample preparation solutions are an excellent complement to our industry-leading automated workstations for genomic applications. Through this acquisition, we are accelerating our broad genomics strategy and further increase our recurring revenues. With further dedicated solution offerings in one of the fastest growing market segments in life sciences, we will be able to enhance the above market average growth of Tecan in years to come. NuGEN will become our center of excellence for NGS reagents and we are delighted to welcome the new colleagues into Tecan."

    Nitin Sood, CEO of NuGEN and designated Vice President and General Manager of Tecan's NGS reagents business, said: "We are very excited to join forces with Tecan to combine our market leading Next Generation Sequencing library preparation technologies with Tecan's core competencies in automation and detection to deliver complete solutions to our customers. Tecan's global footprint and depth of capabilities will accelerate our innovation pipeline, bringing benefits to our customers and employees."

    A leading provider for NGS sample preparation reagents
    NuGEN provides innovative genomic sample preparation for next-generation sequencing (NGS) and microarrays for a broad range of sample types including RNA and DNA from whole tissues, preserved and prepared tissue samples (FFPE, Formalin-Fixed Paraffin-Embedded), single cells and liquid biopsies such as from blood samples. An example of NuGEN's innovation capabilities is the newly launched Celero(TM) DNA-Seq with NuQuant library system which provides researchers with a simplified library preparation workflow with integrated quantification for DNA sequencing. Next-generation sequencing technologies are currently transforming the life sciences, e.g. the field of cancer research, due to the wealth of genetic information obtained.

    NGS workflows are composed of multiple complex steps, several of which need to be performed prior to loading samples in the actual sequencer. The most critical step prior to sequencing is the so called library preparation, in which many samples are processed in parallel and its correct performance is key to match the individual DNA sequences with the respective samples again after sequencing. The quality of prepared libraries has a significant impact on the sequencing process, the reproducibility and usability of the data and thereby ultimately on the overall data quality. With large numbers of samples being processed, library preparation can actually cost more than the sequencing itself.

    The market for library preparation has been expanding with a rate of above 10% and with an estimated size of more than one billion US dollars, it represents a significant share of the overall about 6 billion US dollars sequencing market. Costs associated with NGS overall are dropping, making the technology more affordable and widely accessible. A higher adoption of NGS and fast growing sample numbers increase the need for automation, a particular strength of Tecan, especially in the genomics area. With automation, labs can increase the throughput and eliminate unnecessary manual steps and sources of error. NuGEN's products are automation friendly and offer rapid and simple workflows designed to reduce time and cost per sample. Together with NuGEN, Tecan can leverage its automation expertise and leading position within the market for genomic instruments to offer complete solutions for NGS library preparation, comprising dedicated workstations, accompanying consumables and differentiated NGS reagents. With the Company's global presence, Tecan sees an opportunity to expand the business with an increased presence in North America, Europe as well as expanding sales capabilities in China.

    Established in 2000, NuGEN is well-embedded in the biotech center of the Silicon Valley, California (USA), and has over 70 employees.

    Additional information can be found on the NuGEN webpage:
    www.nugen.com

    About Tecan
    Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2017, Tecan generated sales of CHF 548 million (USD 560 million; EUR 494 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

    For further information:

    Tecan Group
    Martin Braendle
    Vice President, Communications & Investor Relations
    Tel. +41 (0) 44 922 84 30
    Fax +41 (0) 44 922 88 89
    investor@tecan.com
    www.tecan.com

  • Maennedorf, Switzerland, February 05, 2019 – Tecan today announces the launch of NGS DreamPrep, a fully-automated approach to next-generation sequencing (NGS) library preparation for research use. This groundbreaking new approach offers quality controlled, sequencing-ready NGS libraries in just a matter of hours, with minimal manual interaction and no sample loss.

    NGS DreamPrep is a full walkaway solution that combines the Tecan Fluent® liquid handler and Infinite® plate reader, together with Celero™ DNA-Seq and Universal Plus mRNA-Seq library preparation kits – an optimized solution that brings significant improvements in speed, flexibility, accuracy and precision.

    NGS experiments are time-consuming, expensive and generate vast quantities of data. This makes it particularly important that they are based on high-quality libraries that will yield valuable results. With NGS DreamPrep, quantification, normalization and pooling of samples can all be achieved in significantly shorter timelines compared to other methods that use qPCR or capillary electrophoresis. Importantly, this is the first library preparation method to incorporate a QC step, which takes just five minutes, ensuring the generation of highly reproducible libraries that are ready to sequence.

    Dr Klaus Lun, Executive Vice President, Head of the Life Sciences Business Division, Tecan said: “Next-generation sequencing continues to revolutionize genomic research. Previously, the technique relied on libraries being quantified and normalized using methods that were time-consuming and subject to variability. NGS DreamPrep enables users to easily transform samples into high quality, ready-to-use libraries.”

    NGS DreamPrep brings together Tecan’s technical expertise in chemistry and protocol development together with unsurpassed engineering know-how of automation and detection instrumentation to ensure an optimized approach. All elements have been designed to work hand-in-hand and researchers benefit from having a single contact point plus dedicated Tecan application support.

    The Tecan Group acquired US-based NuGEN Technologies, Inc., now named Tecan Genomics, in August 2018 to further expand Tecan's dedicated solutions offering into the new market segment of NGS reagents and kits, making the company the one-stop-shop for genomic sample preparation solutions. The Celero DNA-Seq and Universal Plus mRNA-Seq kits are the first of the company’s NGS kits to be available for the NGS DreamPrep.

    Tecan’s experts will be demonstrating the new NGS DreamPrep on booth 825 at SLAS2019. For further information on the system, visit
    www.tecan.com/ngsdreamprep

    FOR MORE INFORMATION PLEASE CONTACT

    Tecan Genomics, Inc
    KD Modi, Vice President of Marketing

    Tel: 1-650-567-6252
    Fax: 1-888-296-6544

  • Maennedorf, Switzerland, July 30, 2019 – Tecan Partnering has consolidated its extensive OEM system development services for life sciences and IVD instruments to create Tecan Synergence™. Bringing together over 40 years of experience in laboratory automation and OEM instrument development, Tecan Synergence provides a rapid, structured and flexible approach to the creation of OEM solutions, shortening time to market and reducing project risk.

    Tecan understands that every business has different strengths and capabilities, so Synergence is designed to be as flexible as possible while still incorporating all the elements that make up a successful automation project, from product design and development to manufacturing, launch and post-launch activities. Its multidisciplinary team of scientists and engineers work in close partnership with customers to understand their technologies, develop innovative automation concepts and turn concepts into reality. Each tailored platform draws on Tecan’s portfolio of high quality, modular liquid handling systems and renowned Tecan Cavro® brand of OEM liquid handling components to ensure seamless, user-friendly automation of customer workflows.

    Tecan Partnering already supplies more than 35 OEM diagnostic platforms to over 30 customers – from leading diagnostics companies to segment specialists and emerging players – working across the full spectrum of life sciences and diagnostics applications to take emerging technologies from research to routine testing. Nicholas Smith, Head of Global Marketing and Portfolio Management at Tecan, commented: “Our close relationship with our customers means that we understand their diverse workflows and applications. This allows us to develop comprehensive, high quality solutions to help eliminate bottlenecks, improve productivity and ensure that customers’ systems are a success in the marketplace.”

    To learn more about Tecan’s OEM system development services, visit www.tecan.com/synergence

    FOR MORE INFORMATION PLEASE CONTACT

    Tecan Trading AG
    Antonietta Allocca
    Seestrasse 103
    CH-8708 Männedorf

    Tel +41 (0)44 922 81 11
    Fax +41 (0)44 922 81 12

Questions or Need Assistance?

Email exhibits@ashg.org

Technical support: Support

For more tips, visit the FAQ.

Featured Products
View All

Want your product featured here? Click to upgrade your online exhibitor listing.